UPDATE 1-U.S. judge in Texas invalidates Allergan patents on Restasis
October 16, 2017 at 13:45 PM EDT
Oct 16 (Reuters) - Shares of pharmaceutical company Allergan Plc dropped on Monday after a ruling by a U.S. judge invalidated patents on its dry eye medicine Restasis on the grounds that the patents cover obvious ideas.
